Cellorgane® Multi-Complex 3G Formula 3 Heart-Artery-Vein
With age, organ function progressively decreases due to cell deterioration, caused mainly by oxidative stress; this generates vitality and quality of life losses.
This organic sub function predisposes to chronic degenerative diseases.
Damage by oxidative stress and cardiovascular problems.
Metabolic Syndrome, Hypertension, Heart Failure, Atherosclerosis, Diabetes Mellitus type II, Kidney Disease, Varicose ulcers, Varicose veins, Telangiectasias, poorly healing wounds, hypercholesterolemia, Hypertriglyceridemia and obesity.
The contribution of cellular cytokines and growth factors in embryonic extracts has a refreshing and revitalizing effect at the cellular level, which increases the specific functionality of the organ to be treated.
Antioxidant enzymes neutralize free radicals, thereby reducing damage from oxidative stress.
Oral CELLORGANE 3
Each 500-mg enteric coated tablet contains:
Opotherapic cell extracts: Heart 30%, Arteries 10%, formulated enzyme-Therapy 10%, embryonic mesoderm 10% , Thymus 10%, Placenta 10%; Enzyme complex: Biolastin, superoxide dismutase, glutathione peroxidase, glutathione reductase, glutathione transferase; Maltodextrin 20% and stabilizers.
Formula components reach the cells directly or indirectly, in the case of oral products, by bloodstream, and are selectively incorporated into the cells through various means of cellular transport.
It acts revitalizing the circulatory system at the cellular level, improving its functionality and reducing the risk of degenerative diseases.
- Allergies to animal proteins.
- Allergy to any of its components.
- Pregnancy and lactation.
Metabolic Syndrome, Hypertension, Diabetes Mellitus type II, Kidney Disease, Obesity
Two tablets in the morning and 2 at night, for at least six months.
Atherosclerosis, Diabetes Mellitus type II, hypercholesterolemia, hypertriglyceridemia, Varicose ulcers, Varicose veins, Telangiectasias, poorly healing wounds
Two tablets in the morning and 2 at night, for at least three months.
The tablets are taken in the morning on an empty stomach and at night before dinner (30 minutes before meals).
The dose may be increased according to the clinical picture of the patient and the physician's discretion; the results depend on the completion of treatment.